183 related articles for article (PubMed ID: 4540468)
1. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
Trentin JJ; Judd KP
Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
[No Abstract] [Full Text] [Related]
2. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
Richie ER; Gallagher MT; Trentin JJ
Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
[No Abstract] [Full Text] [Related]
3. Inhibition of the graft-versus-host reaction. III. Altered in vivo distribution of spleen cells pretreated with Fab fragments of antithymocyte globulin.
Richie ER; Monié HJ; Trentin JJ; Taub RN
Transplantation; 1975 Feb; 19(2):115-20. PubMed ID: 235162
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
[No Abstract] [Full Text] [Related]
5. Antigen binding strength of T and B lymphocytes after immunization with hapten.
Möller E
Transplant Proc; 1972 Sep; 4(3):357-60. PubMed ID: 5080604
[No Abstract] [Full Text] [Related]
6. In vivo activity of cytotoxic lymphocytes.
Cerottini JC; Freedman LR; Brunner KT
Transplant Proc; 1972 Sep; 4(3):299-301. PubMed ID: 4404149
[No Abstract] [Full Text] [Related]
7. Bone marrow origin of nonsensitized effector cells in skin allograft rejection.
Kongshavn PA; Lapp WS
Transplantation; 1973 Oct; 16(4):382-4. PubMed ID: 4583154
[No Abstract] [Full Text] [Related]
8. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
Rodt H; Thierfelder S; Eulitz M
Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
[No Abstract] [Full Text] [Related]
9. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
[TBL] [Abstract][Full Text] [Related]
10. The graft-versus-host reaction and immune function. II. Recruitment of pre-T-cells in vivo by graft-versus-host-induced dysplastic thymuses following irradiation and bone marrow treatment.
Seddik M; Seemayer TA; Lapp WS
Transplantation; 1984 Mar; 37(3):286-90. PubMed ID: 6142550
[TBL] [Abstract][Full Text] [Related]
11. Dichotomy and improved specificity of immunosuppressive effect of anti-thymocyte globulin.
Judd KP; Bryant CJ; Trentin JJ
J Immunol; 1972 May; 108(5):1461-4. PubMed ID: 4555122
[No Abstract] [Full Text] [Related]
12. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
13. [Clinical trial of antithymocyte globulin for prophylaxis of acute graft-versus-host disease in pediatric recipients of bone marrow transplantation from unrelated donors].
Yagasaki H; Kojima S; Inaba J; Kato K; Matsuyama T
Rinsho Ketsueki; 1999 May; 40(5):382-9. PubMed ID: 10390886
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of segregated lymphocytes.
Lance E; Cooper S
Transplant Proc; 1973 Mar; 5(1):119-24. PubMed ID: 4144456
[No Abstract] [Full Text] [Related]
15. Graft-versus-host disease.
Gatti RA; Kersey JH; Yunis EJ; Good RA
Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
[No Abstract] [Full Text] [Related]
16. Genetic resistance in the graft-versus-host reaction.
Sula K; Nouza K
Exp Clin Immunogenet; 1984; 1(3):175-84. PubMed ID: 6101099
[TBL] [Abstract][Full Text] [Related]
17. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.
Weiden PL; Doney K; Storb R; Thomas ED
Transplant Proc; 1978 Mar; 10(1):213-6. PubMed ID: 345561
[No Abstract] [Full Text] [Related]
18. Inactivation of thymus and marrow-derived lymphocytes by heterologous antilymphocyte serum (ALS).
Jeejeebhoy HF
Transplant Proc; 1971 Mar; 3(1):793-6. PubMed ID: 5095893
[No Abstract] [Full Text] [Related]
19. Modification of graft-vs-host disease following bone marrow transplantation in germfree mice.
Bealmear PM; Mirand EA; Holtermann OA
Prog Clin Biol Res; 1983; 132C():409-21. PubMed ID: 6227014
[No Abstract] [Full Text] [Related]
20. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
